CAXTON CORP
Confidential treatment requested — holdings omitted from public disclosure
13F Reported Value
ⓘ$1.9M
Holdings
10
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
CAXTON CORP disclosed 10 positions worth $1.9M in its Form 13F-HR for Q2 2026, led by $SPCX (SPACE EXPLORATION TECHNOLOGIES CORP) at 24.0% of the equity portfolio, followed by $BRK.B and $GOOG. During the quarter the fund opened 4 new positions and exited 1 — including a new stake in $SPCX and a full exit from $GLD. The portfolio is most concentrated in Technology (37.4% of disclosed assets). All figures are sourced directly from CAXTON CORP’s Form 13F-HR filing with the SEC under CIK 1388551.
AI Fund Analysis
StableSector Allocation
13fpro.ai/research/fund/caxton-corp-1388551
AUM History
13fpro.ai/research/fund/caxton-corp-1388551
Top Equity Holdings by Value
13fpro.ai/research/fund/caxton-corp-1388551
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- $445.3K2,606 sh
- 73.6#124
Quality
$377.1K754 sh - 78.1#58
Quality
$246.9K691 sh VANGUARD INDEX FDS - S&P 500 ETF SHS
—Quality
$233.1K339 sh- 74.2
Quality
$188.2K1,597 sh - —
Quality
$110.0K12,347 sh - —
Quality
$79.0K16,962 sh - 28.0
Quality
$72.7K15,557 sh - —
Quality
$57.8K28,453 sh - —
Quality
$43.4K20,946 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
| — | $445.3K | 2,606 | |
| 73.6#124 | $377.1K | 754 | |
| 78.1#58 | $246.9K | 691 | |
| VANGUARD INDEX FDS - S&P 500 ETF SHS | — | $233.1K | 339 |
| 74.2 | $188.2K | 1,597 | |
| — | $110.0K | 12,347 | |
| — | $79.0K | 16,962 | |
| 28.0 | $72.7K | 15,557 | |
| — | $57.8K | 28,453 | |
| — | $43.4K | 20,946 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of CAXTON CORP's 10 positions.
Showing top 10 of 10 holdings.
Sector Allocation
Technology
$692,252
Financials
$565,346
Healthcare
$362,735
Other
$233,094
Full Holdings — CAXTON CORP (Q2 2026)
All 10 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | SPACE EXPLORATION TECHNOLOGIES CORP | $445,346 | 24.0% | NEW | — | |
| 2 | BERKSHIRE HATHAWAY INC | $377,128 | 20.4% | +4% | 73.6 | |
| 3 | Alphabet Inc. | $246,906 | 13.3% | NEW | 78.1 | |
| 4 | — | VANGUARD INDEX FDS - S&P 500 ETF SHS | $233,094 | 12.6% | NEW | — |
| 5 | Blackstone Inc. | $188,218 | 10.2% | NEW | 74.2 | |
| 6 | Kyverna Therapeutics, Inc. | $110,009 | 5.9% | -34% | — | |
| 7 | Lexeo Therapeutics, Inc. | $78,959 | 4.3% | +22% | — | |
| 8 | X4 Pharmaceuticals, Inc | $72,650 | 3.9% | +0% | 28 | |
| 9 | Inhibikase Therapeutics, Inc. | $57,759 | 3.1% | +0% | — | |
| 10 | ALX ONCOLOGY HOLDINGS INC | $43,358 | 2.3% | +0% | — |
New Positions (4)
Exited Positions (1)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for CAXTON CORP including:
Track CAXTON CORP's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for CAXTON CORP and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: CAXTON CORP
13F Pro is an AI hedge fund tracker and stock research platform. For CAXTON CORP (SEC CIK: 1388551), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in CAXTON CORP's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.